Lv2
130 积分 2025-03-25 加入
An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis: a multicentre, double-blind, placebo-controlled phase 2b study
2天前
已完结
An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis: a multicentre, double-blind, placebo-controlled phase 2b study
3天前
已完结
Once-weekly Lonapegsomatropin was Efficacious and Well Tolerated in Chinese Children with Growth Hormone Deficiency: Results from a Phase 3 Randomized Trial
6天前
已完结
Somapacitan in children with idiopathic short stature: a randomized controlled phase 3 study
6天前
已完结
Validation of growth standards and growth references: A review of literature
6天前
已完结
Cross-Reactive Polyclonal Antibodies Raised Against GalNAc-Conjugated siRNA Recognize Mostly the GalNAc Moiety
7天前
已完结
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study
7天前
已完结
Evaluation of the safety and efficacy of biosimilar recombinant growth hormone in children with growth hormone deficiency: non-inferiority, randomized, parallel, multicentric and Phase III trial
9天前
已完结
Overview on the management of herpes simplex virus infections: Current therapies and future directions
9天前
已完结
FUNGAL NAIL INFECTIONS: A SYSTEMATIC REVIEW OF EPIDEMIOLOGY, DIAGNOSIS, AND THERAPEUTIC APPROACHES
13天前
已关闭
皖公网安备34019202002308
